0001415889-15-002172.txt : 20150826 0001415889-15-002172.hdr.sgml : 20150826 20150623201251 ACCESSION NUMBER: 0001415889-15-002172 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MetaStat, Inc. CENTRAL INDEX KEY: 0001404943 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 208753132 STATE OF INCORPORATION: NV FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVE., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (212)796-8170 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVE., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Photovoltaic Solar Cells, Inc. DATE OF NAME CHANGE: 20070627 CORRESP 1 filename1.htm mtstcorresp.htm
METASTAT, INC.
27 DryDock Ave, 2nd Floor
Boston, MA 02210

 
June 23, 2015
 
Kate Maher, Esq.
Securities and Exchange Commission
100 F. Street, N.E.
Washington, D.C. 20549
 
  
 
 
Re:
MetaStat, Inc.
 
Amendment No. 1 to Registration Statement on Form S-1
 
Filed June 1, 2015
 
File No. 333-203361

Dear Ms. Maher:
 
On behalf of MetaStat, Inc., a Nevada corporation (the “Company”), we hereby provide a response to the comments issued in a letter dated June 11, 2015 (the “Staff’s Letter”) regarding the Company’s Registration Statement on Form S-1, as amended (the “Form S-1”). Contemporaneously with this submission, we have filed a further amended Registration Statement on Form S-1 (the “Amended Form S-1”) reflecting the responses of the Company below.  In addition, the Amended Form S-1 reflects revised disclosure with respect to certain recent developments as summarized in the prospectus summary of the Amended Form S-1, including recent changes to management. To facilitate the review by the Commission’s staff (the “Staff”) of the Amended Form S-1, we have responded, on behalf of the Company, to the comment set forth in the Staff’s Letter as follows:
 
Comment
Number
 
Comment and Response
 
Certain Relationships and Related Transactions, and Director Independence, page 83
 
1.
Please name the related persons involved with each transaction required to be disclosed by Regulation S-K Item 404. In this regard, we note that you name Dr. David Epstein as “one of [y]our directors” in this section; please tell us where you disclose the information required by Regulation S-K Item 401 regarding this director.
 
COMPANY RESPONSE:  We have revised the disclosure in this section to indicate that Dr. Epstein is a former director and resigned from the board of directors on May 16, 2015.
 
Selling Stockholders, page 84
 
2.
Please revise your disclosure added in response to the second sentence of prior comment 2 to clarify whether the services that the broker-dealers provided in exchange for the offered securities were underwriting activities. Also, please tell us whether each of the broker-dealers mentioned in the penultimate paragraph of page 84 was registered under the Securities Exchange Act of 1934 as a broker-dealer at the time that it engaged in underwriting activities in connection with your securities offerings.
 
COMPANY RESPONSE:  We have revised the disclosure in accordance with the Staff’s comment to clarify the services that the broker-dealers provided in exchange for the offered securities were underwriting activities and that such broker-dealers were registered under the Exchange Act at the time that they engaged in underwriting activities in connection with our securities offerings.
 
***
 
Thank you very much for your time and attention in connection with this filing. Should you have any questions concerning any of the foregoing, please contact David J. Levine, Esq., of Loeb & Loeb LLP, counsel to the Company, by telephone at (212) 407-4923.
 
Sincerely,

/s/ Douglas A. Hamilton                                           
Douglas A. Hamilton, CEO